Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Garovaglio & Zorraquin's Total Liabilities for the quarter that ended in Mar. 2026 was ARS41,127 Mil.
Garovaglio & Zorraquin's quarterly Total Liabilities
increased
from Sep. 2025 (ARS39,923.91 Mil) to Dec. 2025 (ARS41,641.69 Mil) but then
declined
from Dec. 2025 (ARS41,641.69 Mil) to Mar. 2026 (ARS41,126.94 Mil).
Garovaglio & Zorraquin's annual Total Liabilities
increased
from Jun. 2023 (ARS26,763.23 Mil) to Jun. 2024 (ARS30,290.61 Mil) and
increased
from Jun. 2024 (ARS30,290.61 Mil) to Jun. 2025 (ARS37,417.61 Mil).
Garovaglio & Zorraquin Total Liabilities Related Terms
Garovaglio & Zorraquin Total Liabilities Historical Data
* Premium members only.
The historical data trend for Garovaglio & Zorraquin's Total Liabilities can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Garovaglio & Zorraquin Total Liabilities Calculation
Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.
Garovaglio & Zorraquin's Total Liabilities for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Total Liabilities of ARS41,127 Mil mean?
Garovaglio & Zorraquin (BUE:GARO) has a Total Liabilities of ARS41,127 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Garovaglio & Zorraquin and its competitors.
Is Garovaglio & Zorraquin's Total Liabilities too high?
Garovaglio & Zorraquin's current Total Liabilities is ARS41,127 Mil. Overall, Garovaglio & Zorraquin has a GF Score™ of 53/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Garovaglio & Zorraquin's Total Liabilities compare to HON and MMM?
Garovaglio & Zorraquin's Total Liabilities of ARS41,127 Mil can be compared against companies in the Conglomerates industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Conglomerates company?
A good Total Liabilities depends on the Conglomerates industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Garovaglio & Zorraquin and its competitors. Garovaglio & Zorraquin's current Total Liabilities is ARS41,127 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Garovaglio & Zorraquin stock overvalued right now?
Based on GuruFocus' analysis, Garovaglio & Zorraquin (BUE:GARO) is currently considered Significantly Overvalued. The stock's GF Value™ is ARS161.58, compared to a current price of ARS473.00 — trading 192.7% above its estimated fair value. The current Total Liabilities is ARS41,127 Mil. Garovaglio & Zorraquin's overall GF Score™ is 53/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Garovaglio & Zorraquin (BUE:GARO), the current Total Liabilities is ARS41,127 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Garovaglio & Zorraquin (BUE:GARO) Overvalued in 2026?
Based on GuruFocus' analysis, Garovaglio & Zorraquin stock appears to be overvalued.
The current stock price of ARS473.00 is trading 192.7% above its estimated GF Value™ of ARS161.58.
GuruFocus considers Garovaglio & Zorraquin to be Significantly Overvalued.
Key valuation signals for BUE:GARO:
Total Liabilities: ARS41,127 Mil
GF Value™: ARS161.58 vs. price of ARS473.00 (192.7% above fair value)
No single metric tells the full story. See the BUE:GARO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Garovaglio & Zorraquin SA is a holding company that provides services in the real estate, financial, petrochemical agricultural sectors and among others.
53GF Score
Get the complete analysis for BUE:GARO
Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BUE:GARO has been successfully added to your 
